miR-208-3p promotes hepatocellular carcinoma cell proliferation and invasion through regulating ARID2 expression (Q28115691)

3 January 2017

title

miR-208-3p promotes hepatocellular carcinoma cell proliferation and invasion through regulating ARID2 expression (English)

1 reference

AT-rich interaction domain 2

3 January 2017

main subject

1 reference

transforming growth factor beta 1

GOA release 2020-03-11

1 reference

negative regulation of cell migration

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

hepatocellular carcinoma

1 reference

Peng Yu

1

1 reference

3 January 2017

Dingguo Wu

2

1 reference

3 January 2017

Yu You

3

1 reference

3 January 2017

Jing Sun

4

1 reference

3 January 2017

Lele Lu

5

1 reference

3 January 2017

Jiaxing Tan

6

1 reference

3 January 2017

Ping Bie

7

1 reference

3 January 2017

publication date

15 August 2015

1 reference

3 January 2017

10 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A26169693

https://europepmc.org/articles/PMC7094640

19 February 2026

language of work or name

English

0 references

work available at URL

file format

HyperText Markup Language

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A26169693

https://europepmc.org/articles/PMC7094640?pdf=render

19 February 2026

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A26169693

https://api.elsevier.com/content/article/PII:S0014482715300380?httpAccept=text/xml

19 February 2026

1 reference

10.1016/J.YEXCR.2015.07.008

DOI

https://api.crossref.org/works/10.1016/J.YEXCR.2015.07.008

https://api.elsevier.com/content/article/PII:S0014482715300380?httpAccept=text/plain

19 February 2026

1 reference

10.1016/J.YEXCR.2015.07.008

DOI

https://api.crossref.org/works/10.1016/J.YEXCR.2015.07.008

Experimental Cell Research

19 February 2026

published in

1 reference

3 January 2017

volume

336

1 reference

3 January 2017

issue

2

1 reference

3 January 2017

page(s)

232–241

1 reference

HCC therapies—lessons learned

3 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Biomarkers for virus-induced hepatocellular carcinoma (HCC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Complementary miRNA pairs suggest a regulatory role for miRNA:miRNA duplexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

The prognostic importance of miR-21 in stage II colon cancer: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

let-7 microRNA functions as a potential growth suppressor in human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Distinct microRNA Expression Profiles in Prostate Cancer Stem/Progenitor Cells and Tumor-Suppressive Functions of let-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

miR-208-Induced Epithelial to Mesenchymal Transition of Pancreatic Cancer Cells Promotes Cell Metastasis and Invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Differential targeting of two distinct SWI/SNF-related Drosophila chromatin-remodeling complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

ARID2: a new tumor suppressor gene in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

How Ebola virus counters the interferon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

ISG56 and IFITM1 proteins inhibit hepatitis C virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

IFITM1 plays an essential role in the antiproliferative action of interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Mechanical stretch via transforming growth factor‐β1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Increased TGF‐β1‐mediated suppression of growth and motility in castrate‐resistant prostate cancer cells is consistent with Smad2/3 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.008

Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice

7 January 2021

1 reference

https://pubmed.ncbi.nlm.nih.gov/26169693

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26169693

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Integration of genomic information in the clinical management of HCC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26169693

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2015.07.008

1 reference

Consolidated OpenCitations Corpus – April 2017

1229196

1229196

1 reference

Consolidated OpenCitations Corpus – April 2017

National Center for Biotechnology Information

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=26169693

19 February 2026

1 reference

Consolidated OpenCitations Corpus – April 2017